S'abonner

Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006 - 20/10/11

Doi : 10.1016/j.jaad.2011.05.034 
Xiao-Cheng Wu, MD, MPH a, , Melody J. Eide, MD, MPH b, Jessica King, MPH (CDC) c, Mona Saraiya, MD, MPH (CDC) c, Youjie Huang, MD, MPH, DrPH e, Charles Wiggins, PhD f, Jill S. Barnholtz-Sloan, PhD g, Nicolle Martin, MD, MPH h, Vilma Cokkinides, PhD i, Jacqueline Miller, MD (CDC) c, Pragna Patel, MD, MPH (CDC) d, Donatus U. Ekwueme, PhD (CDC) c, Julian Kim, MD, FACS j
a Louisiana Tumor Registry, Epidemiology Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana 
b Departments of Dermatology and Biostatistics and Research Epidemiology, Henry Ford Hospital, Detroit, Michigan 
c Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 
d Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 
e Bureau of Epidemiology, Florida Department of Health, Tallahassee, Florida 
f New Mexico Tumor Registry, University of New Mexico, Albuquerque, New Mexico 
g Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio 
h Department of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, Georgia 
i American Cancer Society, Atlanta, Georgia 
j Department of Surgery, Division of Surgical Oncology, University Hospitals Case Medical Center, Cleveland, Ohio 

Reprint requests: Xiao-Cheng Wu, MD, MPH, 1615 Poydras St, Suite 1400, New Orleans, LA 70112.

Abstract

Background

Most melanoma studies use data from the National Cancer Institute Surveillance, Epidemiology, and End Results Program or individual cancer registries. Small numbers of melanoma cases have limited in-depth analyses for all racial and ethnic groups.

Objective

We sought to describe racial and ethnic variations in melanoma incidence and survival.

Methods

Incidence for invasive melanoma and 5-year melanoma-specific survival were calculated for whites, blacks, American Indians/Alaskan Natives, Asians/Pacific Islanders (API), and Hispanics using data from 38 population-based cancer registries.

Results

Incidence rates of melanoma were significantly higher for females than males among whites and Hispanics under 50 years of age and APIs under 40 years of age. White and black patients were older (median age: 59-63 years) compared with Hispanics, American Indians/Alaskan Natives, and API (median age: 52-56 years). The most common histologic type was acral lentiginous melanoma among blacks and superficial spreading melanoma among all other racial and ethnic groups. Hispanics had the highest incidence rate of acral lentiginous melanoma, significantly higher than whites and API. Nonwhites were more likely to have advanced and thicker melanomas at diagnosis and lower melanoma-specific survival compared with whites.

Limitations

Over 50% of melanoma cases did not have specified histology. The numbers of nonwhite patients were still relatively small despite broad population coverage (67% of United States).

Conclusions

Racial and ethnic differences in age at melanoma diagnosis, anatomic sites, and histologic types suggest variations in etiologic pathways. The high percentages of advanced and thicker melanomas among nonwhites highlight the need to improve melanoma awareness for all race and ethnicity in the United States.

Le texte complet de cet article est disponible en PDF.

Key words : anatomic sites, cancer registry, histology, incidence, melanoma, race and ethnicity, survival

Abbreviations used : AI/AN, ALM, API, CDC, LMM, NCI, NPCR, SEER, SSM, SS2000


Plan


 Publication of this supplement to the JAAD was supported by the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention (CDC). Dr Kim was supported by National Institutes of Health K23 CA109115-01A3.
 Conflicts of interest: None declared.
 The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions, recommendations, or official position of the journal editors or the Centers for Disease Control and Prevention.


© 2011  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 65 - N° 5S1

P. S26.e1-S26.e13 - novembre 2011 Retour au numéro
Article précédent Article précédent
  • Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006
  • Ahmedin Jemal, Mona Saraiya, Pragna Patel, Sai S. Cherala, Jill Barnholtz-Sloan, Julian Kim, Charles L. Wiggins, Phyllis A. Wingo
| Article suivant Article suivant
  • Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006
  • Hannah K. Weir, Loraine D. Marrett, Vilma Cokkinides, Jill Barnholtz-Sloan, Pragna Patel, Eric Tai, Ahmedin Jemal, Jun Li, Julian Kim, Donatus U. Ekwueme

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.